CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management

Kang Min Lee, Hee Woo Lee, Seung Yeon Kim, Hyeon Jeong Lee, Dong Hwan Kim, Joongbum Cho, Dong Ho Kim, Jung Sub Lim, Jin Kyung Lee, Jun Ah Lee

Cancer Research and Treatment. 2011;43(1):67-70. Published online 2011 March 31 DOI: https://doi.org/10.4143/crt.2011.43.1.67

Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management

Kang Min Lee, Hee Woo Lee, Seung Yeon Kim, Hyeon Jeong Lee, Dong Hwan Kim, Joongbum Cho, Dong Ho Kim, Jung Sub Lim, Jin Kyung Lee, Jun Ah Lee

Cancer Research and Treatment. 2011;43(1):67-70

Link1

Link2

Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion

Brigitte C. Widemann

Pediatric Blood & Cancer. 2015;63(2):366-366

Link1 Link2

Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion

Jeffrey R. Scott, Kristine R. Crews

Pediatric Blood & Cancer. 2015;63(2):365-365

Link1 Link2

Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion

Paul A. Meyers

Pediatric Blood & Cancer. 2015;63(2):364-364

Link1 Link2

Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma

Jeffrey R. Scott, Deborah A. Ward, Kristine R. Crews, John C. Panetta, Fariba Navid

Pediatric Blood & Cancer. 2013;61(2):373-375

Link1 Link2 Link3

Different cross-reactivity profiles of methotrexate immunoassays and the clinical management of methotrexate treatment

Yifei Yang, Kiang-Teck J. Yeo

Toxicology Cases for the Clinical and Forensic Laboratory. 2020;165-167

Link1 Link2

Methotrexate pharmacokinetics and survival in osteosarcoma

Irene Aquerreta, Azucena Aldaz, Joaquín Giráldez, Luis Sierrasesúmaga

Pediatric Blood & Cancer. 2003;42(1):52-58

Link1 Link2

Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma

Elizabeth P. Young, W. Susan Cheng, Melanie B. Bernhardt, Lisa L. Wang, Nino Rainusso, Jennifer H. Foster

Pediatric Blood & Cancer. 2019;67(4):

Link1 Link2 Link3 Link4

Cola beverage and delayed elimination of methotrexate

Raoul Santucci, Dominique Levêque, Raoul Herbrecht

British Journal of Clinical Pharmacology. 2010;70(5):762-764

Link1 Link2

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide

Feng LIN, Qiong WANG, Wenxi YU, Lina TANG, Shuier ZHENG, Yuanjue SUN, Zan SHEN, Yang YAO, Yang DONG

Asia-Pacific Journal of Clinical Oncology. 2011;7(3):270-275

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.